ADCs Safety Profile: How to Identify Their AEs and How to Manage

ESGO eAcademy, Angelica Rodrigues, 4151773

Empowering Care: The Mallow Flower Collaborative Approach to Sexual Health Education and Support

ESGO eAcademy, Ico Toth, 4151776

Surgical Resection Of A Hepato-Gastric Recurrence Of A High Grade Serous Ovarian Cancer

ESGO eAcademy, Giulio Ricotta, 4151767

Mapping Patient Needs: Insights and Actions from Sexual Health Survey in Gynaecologic Oncology

ESGO eAcademy, Zoia Razumova, 4151775

A Paradigm Shift in the Treatment of Gyn Tumours: ADCs

ESGO eAcademy, Antonio Gonzalez Martin, 4151772

Transvaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) Pelvic, Para-Aortic Lymph Node Dissection and Omentectomy via Transperitoneal Approach in Patient with Ovarian Cancer

ESGO eAcademy, Rabia Merve Palalıoğlu, 4151766

Ultrasound Assessment of Lymph Nodes for Staging of Gynecological Cancer: Consensus Opinion on Terminology and Examination Technique

ESGO eAcademy, Elena Gatti, 4151765

Reclaiming Intimacy: The Patient Journey Through Sexual Health During and After Gynaecologic Cancer Treatment

ESGO eAcademy, Kim Hulscher, 4151774

Delving into ADCs Structure and Mechanism of Action

ESGO eAcademy, Toon Van Gorp, 4151771

PSOGI-ESGO-ISSPP Consensus on Peritonectomy Procedures

ESGO eAcademy, Artem Stepanyan, 4151764

SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study

ESGO eAcademy, Jianqing Zhu, 4151760

Prospective Assessment Of The Association Between Perioperative Fluid Balance And Postoperative Complications After Surgery For Advanced Ovarian Cancer; Ancillary Data From A Randomised Controlled Trial

ESGO eAcademy, Sahar Salehi, 4151759

Effect Of Crossover-Surgery At The Subsequent Relapse On The Survival Of Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Prespecified And Post-Hoc Analyses Of The SOC-1 Randomized Phase 3 Trial

ESGO eAcademy, Yulian Chen, 4151758

Which Systemic Therapies are Indicated?

ESGO eAcademy, Angelica Rodrigues, 4151752

Case Presentation - Endometrial cancer challenges

ESGO eAcademy, Olfa Jaidane, 4151763

Stereotactic Ablative Radiotherapy for Oligometastatic Ovarian Cancer Parenchymal Disease: The MITO-RT3/RAD Phase II Trial

ESGO eAcademy, Gabriella Macchia, 4151757

Updated Patient-Reported Outcomes In The PRIMA/ENGOT-OV26/GOG-3012 Trial Of Niraparib First-Line Maintenance Therapy In Patients With Newly Diagnosed Advanced Ovarian Cancer

ESGO eAcademy, Domenica Lorusso, 4151756

Challenging Settings Facing Endometrial Cancer Tumour Boards in Limited Resources Settings

ESGO eAcademy, Basel Refky, 4151762

When are RT and Ablative Therapies Indicated?

ESGO eAcademy, Alina Sturdza, 4151751

Efficacy Of Secondary Cytoreductive Surgery In Recurrent Low-Grade Serous Ovarian Cancer: A Multicenter Retrospective Analysis

ESGO eAcademy, Thomas Gaillard, 4151755

Impact Of Ascites And Peritoneal Metastatic Lesion Volumes, Measured By Newly Developed Deep Learning-Based Algorithm, In Advanced Epithelial Ovarian Cancer

ESGO eAcademy, Se Ik Kim Kim, 4151754

Association Between BRCA1 And BRCA2 Mutations With Toxicity From Olaparib In Platinum Sensitive Relapsed High Grade Ovarian Cancer

ESGO eAcademy, Giorgia Russo, 4151753

Challenging Settings Facing Cervical Cancer Tumour Boards in Limited Resources Settings, 8 Years Experience

ESGO eAcademy, Olga P Matylevich, 4151761

The Role of Surgery and Indication

ESGO eAcademy, Nicolo Bizzarri, 4151750

Immediate Lymphatic Reconstruction At Time Of Inguinofemoral Lymphadenectomy For Patients With Vulvar Cancer

ESGO eAcademy, Maureen Byrne, 4151743

Treatment of Cervical Cancer: ICIS and Beyond

ESGO eAcademy, Nicoletta Colombo, 4151746

Image-Guided Robotic Surgery For Sentinel Lymph Node Status Assessment In Uterine Cancers Using Ultrasound Drop-In Probe: Surgical Technique In 10 Steps

ESGO eAcademy, Matteo Pavone, 4151742

Urethral Neovestibule Reconstruction After Ultraradical Vulvar Surgery: The Gemelli Technique

ESGO eAcademy, Sara Ammar, 4151741

Durvalumab plus Carboplatin/Paclitaxel Followed by Durvalumab with or without Olaparib as First-Line Treatment for Endometrial Cancer: Patient-Reported Outcomes in the DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat Population and by Mismatch Repair Status

ESGO eAcademy, Larissa Meyer, 4151737

What’s New in Ovarian Cancer?

ESGO eAcademy, Jonathan Ledermann, 4151745

Gyn-Twin Study: 3D Digital Twin For Precision Surgery In Gynecological Neoplasms

ESGO eAcademy, Andrea Rosati, 4151740

Pembrolizumab Or Placebo Plus Adjuvant Chemotherapy With Or Without Radiotherapy In Patients With Newly Diagnosed, High-Risk Endometrial Cancer: Exploratory Analysis Of Disease-Specific Survival From The Phase 3 ENGOT-En11/GOG-3053/KEYNOTE-B21 Study

ESGO eAcademy, Toon Van Gorp, 4151736

New Advances in Endometrial Cancer

ESGO eAcademy, Amanda Fader, 4151744

Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study

ESGO eAcademy, Giorgio Valabrega, 4151735

Considerations for Patients Receiving ADCs in the Platinum-Resistant Setting

ESGO eAcademy, Jose Alejandro Perez-Fidalgo, 4151721

ADC-Based Treatment Strategies: Benefits and Drawbacks of Different Antibodies and Linkers, How to Manage Treatment Sequencing

ESGO eAcademy, Isabelle Ray-Coquard, 4151720

Biology of the Disease, Testing Considerations, Current and Emerging Therapies

ESGO eAcademy, Ilaria Colombo, 4151719

Metastatic and Recurrent Disease

ESGO eAcademy, Nicoletta Colombo, 4151701

Adjuvant Therapy: The Guide for Daily Clinical Decision-Making on Whom and How

ESGO eAcademy, Antonio Gonzalez Martin, 4151700

Prognostic Value Of Different Stages Of Maturation Of Tertiary Lymphoid Structures In Molecular Subgroups Of Endometrial Carcinoma

ESGO eAcademy, Manohar Pradhan, 4151717

Five Years Of Real-Life Data In Gynaecological Cancers: A Multicenter Clinical Registry With Associated Samples (GEICO 81-T)

ESGO eAcademy, Fernando Galvez-Montosa, 4151716

Abdominal Cavity Collections

ESGO eAcademy, Santiago Domingo, 4151706

Concordance Of Molecular Class In Matched Primary And Metastatic Endometrial Cancer

ESGO eAcademy, Mari Halle, 4151715

Surgical Cornerstones

ESGO eAcademy, Ignace Vergote, 4151699

Development And Validation Of An Endometrial Cancer Specific CtDNA Panel (ECctDNA) To Detect Cancer Recurrence

ESGO eAcademy, Esther Moss, 4151714

The Headache of the Anastomosis Leakage

ESGO eAcademy, Dennis Chi, 4151705

Hysterectomy Or Not For Borderline Ovarian Tumor In Menopause? Results From A National Multicenter Observational, Retrospective, Cohort Study

ESGO eAcademy, Manuela Maletta, 4151713

Predicting HRD Results In Patient With Ovarian Cancer Using Deep Learning Models On 40x Whole Slide Images

ESGO eAcademy, Ji Hyun Lee, 4151712

Molecular and Conventional Parameters for Classification

ESGO eAcademy, Sigurd Lax, 4151698

The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial

ESGO eAcademy, Madelief Schreuder Goedheijt, 4151711

Diaphragm Complications

ESGO eAcademy, Alejandra Martinez, 4151704

Impact Of Adjuvant (Chemo)Radiation Therapy On Survival In Intermediate-Risk Early-Stage Cervical Cancer

ESGO eAcademy, Anna Norberg Hardie, 4151710

Role Of Prophylactic HPV Vaccination In Patients With Cervical Cancer Treated With Fertility Sparing Surgery (CER-VAX 1 Study).

ESGO eAcademy, Nicolò Bizzarri, 4151709

Surgical Site Complications (including SSI and Abdominal Wall Dehiscence)

ESGO eAcademy, Santiago Domingo, 4151703

Molecular Integrated Risk Group Stratification

ESGO eAcademy, Remi Nout, 4151697

Prophylactic Bilateral Salpingo-Oophorectomy With VNOTES: A New Era In Cancer Prevention Strategies

ESGO eAcademy, Maria Pellise Tintore, 4151708

Implementing High-Risk Human Papillomavirus Self-Sampling For Cervical Cancer Screening In Ghana: A Pilot Study (CarciSCAN)

ESGO eAcademy, Nadja Taumberger, 4151707

DVT/PE in the ERAS Era!

ESGO eAcademy, Alejandra Martinez, 4151702

Introduction to ESGO-ESTRO-ESP Updated Endometrial Cancer Guidelines (with ENGAGe)

ESGO eAcademy, Nicole Concin, 4151696

Immunotherapy Treatment Approaches for Locally Advanced Cervical Cancer

ESGO eAcademy, Gabriella Macchia, 4151684

How to Select the Best Treatment for Your Patients: From Science to Clinical Practice

ESGO eAcademy, Iain McNeish, 4151688

Endometrial Cancer: Exploring 1L Options for Non-dMMR Patients

ESGO eAcademy, Christian Marth, 4151682

Welcome and Introductions

ESGO eAcademy, Ramez Eskander, 4151681

EU -OSNA, A Multicentre European Diagnostic Performance Study Of One-Step Nucleic Acid Amplification Analysis Of Sentinel Lymphatic Nodes In Endometrial Cancer Patients

ESGO eAcademy, Jan Kostun, 4151680

Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation

ESGO eAcademy, Els Van Nieuwenhuysen, 4151679

Prognostic Significance Of Isolated Tumor Cells In Sentinel Lymph Nodes In Low- And Intermediate-Risk Endometrial Cancer Patients: Updated Results From An International Multi-Institutional Study.

ESGO eAcademy, Emilia Palmieri, 4151678

Added Prognostic Value Of Sentinel Lymph Node Mapping In Endometrial Cancer To Molecular Subgroups

ESGO eAcademy, Franziska Siegenthaler, 4151677

Is Immunotherapy in LACC for All? Any Other Alternative? And Which Combination for the Future?

ESGO eAcademy, Mansoor Raza Mirza, 4151673

Improving Endometrial Cancer Assessment By Combining The New TechniqUe Of GENomic Profiling With Surgical Extra UterIne DisEase Assessment (EUGENIE). Second Interim Analysis After Two Years Of Enrolment.

ESGO eAcademy, Rita Trozzi, 4151676

Time Course Of Adverse Events In Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Chemotherapy In The ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial

ESGO eAcademy, David Cibula, 4151675

Artificial Intelligence-Based Models For Early Detection Of Endometrial Cancer And Atypical Hyperplasia From Transvaginal Ultrasound Images

ESGO eAcademy, Diletta Fumagalli, 4151674

Is there a Place for Immunotherapies in LACC?

ESGO eAcademy, Bradley J. Monk, 4151672

4 new Algorithms in Rare Cancers

ESGO eAcademy, Richard Schwameis, 4151660

Immunotherapy and Other Hot News in GTN

ESGO eAcademy, Michael Seckl, 4151659

Novel Therapies in Rare Uterine Tumours

ESGO eAcademy, David Tan, 4151658

Clinical Case Study Illustrating the New ESGO-INCIP Guideline on Gynaecological Cancer During Pregnancy: Interactive session

ESGO eAcademy, Frederic Amant, 4151663

Clinical Case Study Illustrating the New ESGO-INCIP Guideline on Gynaecological Cancer During Pregnancy: Interactive session

ESGO eAcademy, Michael Halaska, 4151662

Hot Topics in 2025 for Rare Ovarian Tumours

ESGO eAcademy, Isabelle Ray-Coquard, 4151657

Interval Debulking Surgery + HIPEC; Robotic-Assisted Radical Hysterectomy; Hysteroscopic Resection of Endometrial Cancer; V-note Approach for Low-risk Endometrial Cancer

ESGO eAcademy, Anna Fagotti, 4151653

Clinical Case Study Illustrating the New ESGO-INCIP Guideline on Gynaecological Cancer During Pregnancy: Interactive session

ESGO eAcademy, Antonia Carla Testa, 4151661

"All Roads Lead to Rome" Historical Lecture

ESGO eAcademy, Costantino D’Orazio, 4151652

ESGO Database Project Winners Announcement - ESGO 2025 congress

ESGO eAcademy, Nicole Concin, 4151651

IJGC Awards ESGO 2025

ESGO eAcademy, Pedro Ramirez, 4151650

Lifetime Achievement Award: Introduction of the Award Winner ESGO 2025

ESGO eAcademy, Luis Chiva, 4151649

Welcome speeches ESGO 2025 congress

ESGO eAcademy, Isabelle Ray-Coquard, 4151647

Welcome speech ESGO 2025 congress

ESGO eAcademy, Anna Fagotti, 4151646

Pelvic Anterior Exenteration For Cervical Cancer Recurrence By Robotic Approach

ESGO eAcademy, Marc Zarzoso Gimenez, 4151639

How to Improve Patient – Doctor Communication

ESGO eAcademy, Annette Hasenburg, 4151645

Oligometastatic Disease in Gynecological Malignancies: To Irradiate or Not to Irradiate?

ESGO eAcademy, Gabriella Macchia, 4151642

Radical Colpohysterectomy : A Step-By-Step Video Guide Of A Single-Patient Case

ESGO eAcademy, Marie Bouabdallah, 4151638

Selective Systematic Nerve-Sparing Type C2 Radical Hysterectomy

ESGO eAcademy, Ilker Selcuk, 4151637

Patient Participation in Clinical Trials

ESGO eAcademy, Joachim Weis, 4151644

Overview on Endometrial and Vaginal Cancer

ESGO eAcademy, Remi Nout, 4151641

Spiralized Rectus Abdominis Muscle (SRAM) Flap For Total Vaginal Reconstruction: Case Report Of A Novel Technique

ESGO eAcademy, Oytun Turkkan, 4151636

Shared Decision Making - How to Survive

ESGO eAcademy, Elisabeth Andritsch, 4151643

Overview on Cervical and Vulvar Cancer

ESGO eAcademy, Alina Sturdza, 4151640

Laterally Extended Pelvic Resection

ESGO eAcademy, Giulio Ricotta, 4151635

Impact of Adjuvant Radiotherapy on Fatigue in Gynaecological Cancer Patients: A 20-Year Single Institutional Experience in 501 Patients

ESGO eAcademy, PAOLO BONOME, 4151634

Impact Of An Enhanced Recovery After Surgery Program On Outcomes In Elderly Patients Undergoing Open Gynecologic Oncology Surgery

ESGO eAcademy, Maria Iniesta, 4151633

ESGO Quiz results

ESGO eAcademy, Marie Plante, 4152024